SG11201903059SA - New anthelmintic quinoline-3-carboxamide derivatives - Google Patents

New anthelmintic quinoline-3-carboxamide derivatives

Info

Publication number
SG11201903059SA
SG11201903059SA SG11201903059SA SG11201903059SA SG11201903059SA SG 11201903059S A SG11201903059S A SG 11201903059SA SG 11201903059S A SG11201903059S A SG 11201903059SA SG 11201903059S A SG11201903059S A SG 11201903059SA SG 11201903059S A SG11201903059S A SG 11201903059SA
Authority
SG
Singapore
Prior art keywords
international
quinoline
monheim
str
pounds
Prior art date
Application number
SG11201903059SA
Inventor
Walter Hübsch
Johannes Köbberling
Adeline Köhler
Hans-Georg Schwarz
Daniel Kulke
Claudia Welz
Thomas Ilg
Kirsten Börngen
Wei Zhuang
Nils Griebenow
Claudia Böhm
Niels Lindner
Maike Hink
Ulrich Görgens
Original Assignee
Bayer Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Animal Health Gmbh filed Critical Bayer Animal Health Gmbh
Publication of SG11201903059SA publication Critical patent/SG11201903059SA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Abstract

INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization 1111111111101110101011111 01111101 0 0111111011110 11111 001 101111110 1111 0111111 International Bureau (10) International Publication Number (43) International Publication Date ......0\" WO 2018/087036 Al 17 May 2018 (17.05.2018) WIPO I PCT (51) International Patent Classification: C07D 215/54 (2006.01) C07D 405/14 (2006.01) CO7D 215/56 (2006.01) A61K 31/47 (2006.01) CO7D 405/12 (2006.01) A61P 33/10 (2006.01) KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, (21) International Application Number: TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. PCT/EP2017/078319 (84) Designated States (unless otherwise indicated, for every (22) International Filing Date: 06 November 2017 (06.11.2017) kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, (25) Filing Language: English TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, (26) Publication Language: English EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, (30) Priority Data: 16198550.2 11 November 2016 (11.11.2016) EP TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). (71) Applicant: BAYER ANIMAL HEALTH GMBH Declarations under Rule 4.17: [DE/DE]; Kaiser-Wilhelm-Allee 10, 51373 Leverkusen — as to applicant's entitlement to apply for and be granted a (DE). patent (Rule 4.17(ii)) (72) Inventors: HUBSCH, Walter; Wildsteig 22, 42113 Wup- pertal (DE). KOBBERLING, Johannes; Azalienstr. 30, 41466 Neuss (DE). KOHLER, Adeline; Heimchenweg 9, 40764 Langenfeld (DE). SCHWARZ, Hans-Georg; Published: — with international search report (Art. 21(3)) Auf dem Beerenkamp 82b, 46282 Dorsten (DE). KULKE, Daniel; Dillinger Str. 13, 51375 Leverkusen (DE). WELZ, Claudia; An der Ziegelei 14, 40593 Diisseldor (DE). ILG, Thomas; Plotzenseer Strasse 16, 40789 Monheim (DE). BORNGEN, Kirsten; Feldhasenweg 23, 50859 Köln (DE). ZHUANG, Wei; StauffenbergstraBe 13, 40789 Monheim (DE). GRIEBENOW, Nils; Kurfiirstenstr. 39, 41541 Dor- magen (DE). BOHM, Claudia; Im Seefelde 4a, 30457 Hannover (DE). LINDNER, Niels; Bodelschwinghweg 4, 42115 Wuppertal (DE). HINK, Maike; Eugen-Eisele-Weg 6, 71665 Vaihingen/Enz (DE). GORGENS, Ulrich; Fester Str.37, 40882 Ratingen (DE). (74) Agent: BIP PATENTS; Alfred-Nobel-Str. 10, NRW, 40789 Monheim am Rhein (DE). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, ,_ 1 (54) Title: NEW ANTHELMINTIC QUINOLINE-3-CARBOXAMIDE DERIVATIVES tD R 6 R 2 (57) : The present invention covers new quinoline com- pounds of general formula (I) in which A, R 1 , R, R 2 3 , R 4 , R 5 , M A © N' (I) R 6 , and Q are as defined herein, methods of preparing said com- IN 1 1 00 GC 0 ,„ 0 ei ... rl 4 R R pounds, intermediate compounds useful for preparing said cam- pounds, pharmaceutical compositions and combinations compris- ing said compounds and the use of said compounds for manufac- pharmaceutical compositions for the treatment, control and/ or prevention of diseases, in particular of helminth infections, as a sole agent or in combination with other active ingredients.
SG11201903059SA 2016-11-11 2017-11-06 New anthelmintic quinoline-3-carboxamide derivatives SG11201903059SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16198550 2016-11-11
PCT/EP2017/078319 WO2018087036A1 (en) 2016-11-11 2017-11-06 New anthelmintic quinoline-3-carboxamide derivatives

Publications (1)

Publication Number Publication Date
SG11201903059SA true SG11201903059SA (en) 2019-05-30

Family

ID=57321155

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201903059SA SG11201903059SA (en) 2016-11-11 2017-11-06 New anthelmintic quinoline-3-carboxamide derivatives

Country Status (27)

Country Link
US (2) US10889573B2 (en)
EP (1) EP3538512B1 (en)
JP (1) JP7165129B2 (en)
KR (1) KR102595730B1 (en)
CN (1) CN109890793B (en)
AU (1) AU2017357503B2 (en)
BR (1) BR112019009529A2 (en)
CA (1) CA3043298A1 (en)
CL (1) CL2019001292A1 (en)
CO (1) CO2019004776A2 (en)
DK (1) DK3538512T3 (en)
DO (1) DOP2019000117A (en)
ES (1) ES2884073T3 (en)
IL (1) IL266407B (en)
MX (1) MX2019005569A (en)
MY (1) MY196327A (en)
NZ (1) NZ752550A (en)
PH (1) PH12019501034A1 (en)
PL (1) PL3538512T3 (en)
PT (1) PT3538512T (en)
SG (1) SG11201903059SA (en)
SI (1) SI3538512T1 (en)
TW (1) TWI821165B (en)
UA (1) UA126119C2 (en)
UY (1) UY37480A (en)
WO (1) WO2018087036A1 (en)
ZA (1) ZA201903708B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2019015895A (en) 2017-06-30 2020-02-07 Bayer Animal Health Gmbh New azaquinoline derivatives.
US11254661B2 (en) * 2017-08-04 2022-02-22 Bayer Animal Health Gmbh Quinoline derivatives for treating infections with helminths
CA3085675A1 (en) 2017-12-15 2019-06-20 Bayer Animal Health Gmbh Process for preparing antihelmintic 4-amino-quinoline-3-carboxamide derivatives
BR112020022619A2 (en) * 2018-05-09 2021-02-02 Bayer Animal Health Gmbh new quinoline derivatives
EP3643711A1 (en) * 2018-10-24 2020-04-29 Bayer Animal Health GmbH New anthelmintic compounds
US20220064159A1 (en) * 2018-12-18 2022-03-03 Elanco Tiergesundheit Ag Bicyclic derivatives
US20220064160A1 (en) * 2018-12-18 2022-03-03 Elanco Tiergesundheit Ag Bicyclic derivatives
CN113825543A (en) 2019-03-19 2021-12-21 勃林格殷格翰动物保健美国公司 Anthelmintic aza-benzothiophene and aza-benzofuran compounds
US20220242857A1 (en) * 2019-06-07 2022-08-04 Elanco Tiergesundheit Ag Bicyclic derivatives for treating endoparasites
TW202120490A (en) * 2019-07-30 2021-06-01 德商拜耳動物保健有限公司 New isoquinoline derivatives
BR112022012126A2 (en) 2019-12-18 2022-08-30 Intervet Int Bv ANTELMINTHIC COMPOUNDS COMPRISING A QUINOLINE STRUCTURE
BR112022020315A2 (en) 2020-04-09 2022-12-13 Bayer Animal Health Gmbh NEW ANTIHELMINTIC COMPOUNDS
MX2022015038A (en) 2020-05-29 2023-01-04 Boehringer Ingelheim Animal Health Usa Inc Anthelmintic heterocyclic compounds.
US20240059680A1 (en) 2020-11-18 2024-02-22 Elanco Tiergesundheit Ag N-(2,3-dihydro-1,4-benzoxazin-4-yl)-3-isopropyl-7-(2,3,5-trifluorophenyl)benzo-thiophene-2-carboxamide derivatives and similar compounds for the treatment of heartworm infections
TW202237600A (en) 2020-12-04 2022-10-01 瑞士商禮藍動物保健股份有限公司 Bicyclic derivatives
EP4259606A1 (en) 2020-12-11 2023-10-18 Intervet International B.V. Anthelmintic compounds comprising a pyridine structure
AU2021395477A1 (en) 2020-12-11 2023-06-22 Intervet International B.V. Anthelmintic compounds comprising a thienopyridine structure
EP4148052A1 (en) 2021-09-09 2023-03-15 Bayer Animal Health GmbH New quinoline derivatives
AR127495A1 (en) 2021-11-01 2024-01-31 Boehringer Ingelheim Vetmedica Gmbh PYRROLOPYRIDAZINE COMPOUNDS AS ANTIHELMINTICS

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4343804A (en) * 1979-03-26 1982-08-10 A. H. Robins Company, Inc. 4-Amino-3-quinolinecarboxylic acids and esters-antisecretory anti-ulcer compounds
KR840000768A (en) * 1982-07-23 1984-02-27 박이은 Smokeless anthracite stove
DE3639877A1 (en) 1986-11-21 1988-05-26 Bayer Ag HETARYLALKYL SUBSTITUTED 5- AND 6-RINGHETEROCYCLES
US6559145B2 (en) 2000-07-12 2003-05-06 Pharmacia & Upjohn Company Heterocycle carboxamides as antiviral agents
GB0213715D0 (en) 2002-06-14 2002-07-24 Syngenta Ltd Chemical compounds
TWI312272B (en) 2003-05-12 2009-07-21 Sumitomo Chemical Co Pyrimidine compound and pests controlling composition containing the same
GB0414438D0 (en) 2004-06-28 2004-07-28 Syngenta Participations Ag Chemical compounds
RU2394819C2 (en) 2004-10-20 2010-07-20 Кумиай Кемикал Индастри Ко., Лтд. Insecticide, acaricide and namatocide, containing 3-triazolylphenyl sulphide derivative as active component
WO2006103120A2 (en) * 2005-04-01 2006-10-05 Insa Rouen New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents
ES2550398T3 (en) 2005-10-06 2015-11-06 Nippon Soda Co., Ltd. Cross-linked cyclic amine compounds and agents for pest control
JP2008214323A (en) 2007-03-08 2008-09-18 Kyowa Hakko Kogyo Co Ltd Treating and/or prophylactic agent of skin disease
EP2164328B8 (en) 2007-06-08 2013-09-11 Dart Neuroscience (Cayman) Ltd Therapeutic pyrazoloquinoline urea derivatives
JP5268461B2 (en) 2008-07-14 2013-08-21 Meiji Seikaファルマ株式会社 PF1364 substance, its production method, production strain, and agricultural and horticultural insecticide containing the same as an active ingredient
CN101337937B (en) 2008-08-12 2010-12-22 国家农药创制工程技术研究中心 N-benz-3-substituted amino pyrazoles compounds with insecticidal activity
CN101337940B (en) 2008-08-12 2012-05-02 国家农药创制工程技术研究中心 Nitrogen heterocyclic ring dichlorin allyl ether compounds with insecticidal activity
CN101715774A (en) 2008-10-09 2010-06-02 浙江化工科技集团有限公司 Preparation and use of compound having insecticidal activity
EP2184273A1 (en) 2008-11-05 2010-05-12 Bayer CropScience AG Halogen substituted compounds as pesticides
GB0820344D0 (en) 2008-11-06 2008-12-17 Syngenta Ltd Herbicidal compositions
WO2010066780A1 (en) 2008-12-12 2010-06-17 Syngenta Participations Ag Spiroheterocyclic n-oxypiperidines as pesticides
CN102574817A (en) * 2009-09-24 2012-07-11 巴斯夫欧洲公司 Aminoquinazoline compounds for combating invertebrate pests
WO2011085575A1 (en) 2010-01-15 2011-07-21 江苏省农药研究所股份有限公司 Ortho-heterocyclyl formanilide compounds, their synthesis methods and use
AR081721A1 (en) 2010-02-25 2012-10-17 Nippon Soda Co CYCLING AND ACARICIDE AMINA COMPOUND
BR112012030408A2 (en) 2010-05-31 2015-09-29 Syngenta Participations Ag crop breeding method
EP2984930B1 (en) 2010-08-31 2018-10-03 Meiji Seika Pharma Co., Ltd. Pest control agent
CN101967139B (en) 2010-09-14 2013-06-05 中化蓝天集团有限公司 Fluoro methoxylpyrazole-containing o-formylaminobenzamide compound, synthesis method and application thereof
US8791162B2 (en) 2011-02-14 2014-07-29 Merck Sharp & Dohme Corp. Cathepsin cysteine protease inhibitors
WO2013050317A1 (en) 2011-10-03 2013-04-11 Syngenta Limited Polymorphs of an isoxazoline derivative
CN102391261A (en) 2011-10-14 2012-03-28 上海交通大学 N-substituted dioxazine compound as well as preparation method and application thereof
MX2014006317A (en) * 2011-11-28 2014-06-23 Du Pont N- (4 -quinolinylmethyl) sulfonamide derivatives and their use as anthelmintics.
WO2013096151A1 (en) 2011-12-22 2013-06-27 Glaxosmithkline Llc Chemical compounds
TWI566701B (en) 2012-02-01 2017-01-21 日本農藥股份有限公司 Arylalkyloxypyrimidine derivatives and agrohorticultural insecticides comprising said derivatives as active ingredients, and method of use thereof
AR089939A1 (en) 2012-02-09 2014-10-01 Glenmark Pharmaceuticals Sa BICYCLE COMPOUNDS AS INHIBITORS OF mPGES-1
US9334238B2 (en) 2012-03-30 2016-05-10 Basf Se N-substituted pyridinylidenes for combating animal pests
EP2647626A1 (en) 2012-04-03 2013-10-09 Syngenta Participations AG. 1-Aza-spiro[4.5]dec-3-ene and 1,8-diaza-spiro[4.5]dec-3-ene derivatives as pesticides
BR112014026746A2 (en) 2012-04-27 2017-06-27 Dow Agrosciences Llc pesticide compositions and processes related thereto
US9282739B2 (en) 2012-04-27 2016-03-15 Dow Agrosciences Llc Pesticidal compositions and processes related thereto
BR112015014909A2 (en) * 2012-12-20 2017-07-11 Bayer Cropscience Ag aryl sulfide and aryl sulfoxide derivatives as acaricides and insecticides
CN103109816B (en) 2013-01-25 2014-09-10 青岛科技大学 Thiobenzamide compounds and application thereof
CN103232431B (en) 2013-01-25 2014-11-05 青岛科技大学 Dihalogenated pyrazole amide compound and its use
US20140275503A1 (en) 2013-03-13 2014-09-18 Dow Agrosciences Llc Process for the preparation of certain triaryl rhamnose carbamates
US20160081342A1 (en) 2013-05-23 2016-03-24 Syngenta Participations Ag Tank-mix formulations
CN103265527B (en) 2013-06-07 2014-08-13 江苏省农用激素工程技术研究中心有限公司 Anthranilamide compound as well as preparation method and application thereof
CN103524422B (en) 2013-10-11 2015-05-27 中国农业科学院植物保护研究所 Benzimidazole derivative, and preparation method and purpose thereof
CN105636440A (en) 2013-10-17 2016-06-01 美国陶氏益农公司 Processes for the preparation of pesticidal compounds
KR20160072154A (en) 2013-10-17 2016-06-22 다우 아그로사이언시즈 엘엘씨 Processes for the preparation of pesticidal compounds
AR098475A1 (en) * 2013-11-26 2016-06-01 Bayer Cropscience Ag PESTICIDE COMPOUNDS AND USES
RU2695815C9 (en) * 2014-03-24 2019-10-28 Гуандун Чжуншэн Фармасьютикал Ко., Лтд Quinoline derivatives as smo inhibitors
WO2016005276A1 (en) 2014-07-07 2016-01-14 Bayer Cropscience Aktiengesellschaft Process for preparing fluorinated iminopyridine compounds
KR101961581B1 (en) 2015-02-17 2019-03-22 닛뽕소다 가부시키가이샤 Agrochemical composition
KR20180095580A (en) 2015-12-17 2018-08-27 아스텍스 테라퓨틱스 리미티드 Quinoline-3-carboxamide as H-PGDS inhibitor

Also Published As

Publication number Publication date
CN109890793B (en) 2022-11-18
MX2019005569A (en) 2019-09-05
EP3538512B1 (en) 2021-06-16
US20210115026A1 (en) 2021-04-22
DK3538512T3 (en) 2021-07-05
RU2019117917A (en) 2020-12-11
PT3538512T (en) 2021-08-16
JP2019535706A (en) 2019-12-12
SI3538512T1 (en) 2021-09-30
TWI821165B (en) 2023-11-11
AU2017357503B2 (en) 2022-02-17
NZ752550A (en) 2023-03-31
US11505545B2 (en) 2022-11-22
WO2018087036A1 (en) 2018-05-17
UY37480A (en) 2018-06-29
ZA201903708B (en) 2022-11-30
US10889573B2 (en) 2021-01-12
CN109890793A (en) 2019-06-14
CO2019004776A2 (en) 2019-07-31
RU2019117917A3 (en) 2021-03-05
KR20190076980A (en) 2019-07-02
IL266407B (en) 2021-10-31
IL266407A (en) 2019-06-30
PL3538512T3 (en) 2021-11-22
CA3043298A1 (en) 2018-05-17
MY196327A (en) 2023-03-24
TW201829384A (en) 2018-08-16
KR102595730B1 (en) 2023-10-27
EP3538512A1 (en) 2019-09-18
DOP2019000117A (en) 2019-05-31
UA126119C2 (en) 2022-08-17
PH12019501034A1 (en) 2019-12-02
ES2884073T3 (en) 2021-12-10
AU2017357503A1 (en) 2019-05-02
JP7165129B2 (en) 2022-11-02
US20200024264A1 (en) 2020-01-23
CL2019001292A1 (en) 2019-09-27
BR112019009529A2 (en) 2019-07-30

Similar Documents

Publication Publication Date Title
SG11201903059SA (en) New anthelmintic quinoline-3-carboxamide derivatives
SG11202000266VA (en) Quinoline derivatives for treating infections with helminths
SG11201808214TA (en) Pyrazolopyrimidine derivatives
SG11201909243TA (en) New bicyclic pyrazole derivatives
SG11201810366WA (en) 3-oxo-2,6-diphenyl-2,3-dihydropyridazine-4-carboxamides
SG11201907232XA (en) 2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer
SG11201811431VA (en) Multispecific antibodies against cd40 and cd137
SG11201808566WA (en) Polymorphic form of n-{6-(2-hydroxypropan-2-yl)-2-[2-(methylsulphonyl)ethyl]-2h-indazol-5-yl}-6-(trifluoromethyl)pyridine-2-carboxamide
SG11201906436VA (en) Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same
SG11201408405WA (en) Engineered three-dimensional connective tissue constructs and methods of making the same
SG11201811706RA (en) Process for the preparation of microcapsules
SG11201811230RA (en) Compositions and methods for reducing ocular neovascularization
SG11201809470RA (en) Substituted indazoles useful for treatment and prevention of allergic and/or inflammatory diseases in animals
SG11201807913XA (en) Stabilized soluble pre-fusion rsv f proteins
SG11201805368YA (en) Anthelmintic depsipeptide compounds
SG11201808686VA (en) Synthesis of indazoles
SG11201902531QA (en) Liquid pharmaceutical composition
SG11201810318RA (en) Compounds for promoting hair growth and/or inhibiting or delaying hair loss in humans, and compositions for such uses
SG11201806393QA (en) Use of gabaa receptor modulators for treatment of itch
SG11201901850XA (en) Dopamine-b-hydroxylase inhibitors
SG11201809882XA (en) Pharmaceutical combinations for treating cancer
SG11201810078PA (en) Stabilized pre-fusion rsv f proteins
SG11201407575PA (en) 5-amino[1,4]thiazines as bace 1 inhibitors
SG11201811708QA (en) Process for the preparation of microcapsules
SG11201809537VA (en) Urea motif containing compounds and derivatives thereof as antibacterial drugs